# Case Report: Electroacupuncture combined with transcutaneous auricular vagus nerve stimulation for treating antiseizure medication-resistant juvenile myoclonic epilepsy

**Authors:** Yuto Matsuura, Masaaki Murakami, Yuji Kawakubo, Tomomi Sakai

PMC · DOI: 10.3389/fpsyt.2025.1649111 · Frontiers in Psychiatry · 2025-11-11

## TL;DR

A patient with drug-resistant epilepsy saw improved seizure control and quality of life using electroacupuncture and vagus nerve stimulation.

## Contribution

Combining electroacupuncture and taVNS offers a novel non-pharmacological approach for ASM-resistant JME.

## Key findings

- Seizure frequency decreased from multiple daily episodes to one per week after eight sessions.
- Quality of life improved across mental and social domains, with reduced anxiety and better school attendance.
- SF-36 scores showed significant improvements in vitality, bodily pain, and social functioning.

## Abstract

Patients with juvenile myoclonic epilepsy (JME) are frequently resistant to antiseizure medication (ASM) and can have a significantly impaired quality of life (QOL). This case report examines successful treatment of JME using a combination of electroacupuncture and transcutaneous auricular vagus nerve stimulation (taVNS).

A 19-year-old Japanese male with a 5-year history of ASM-resistant JME presented with frequent myoclonic and generalized tonic-clonic seizures, daily premonitory auras, and psychological distress. Despite treatment with sodium valproate and clonazepam, he continued to experience multiple seizures weekly and was unable to attend school due to anxiety. After declining surgical vagus nerve stimulation, he sought acupuncture treatment. Weekly sessions of electroacupuncture (ST36 and LR3) and taVNS targeting the left auricular concha were initiated. From the second session, electroacupuncture was intensified at GV20, GV24, and GB18 due to initial symptom worsening.

Over the course of eight sessions, seizure frequency decreased from multiple daily episodes to a single seizure in the final 4 weeks. Premonitory auras and mild-to-moderate seizures also declined significantly. SF-36 assessments at baseline, 1 month, and 2 months revealed improvements across all subscales except physical functioning, with scores for bodily pain, vitality, and social functioning exceeding national norms at the final assessment. Component summary scores for physical, mental, and role/social functioning also improved consistently. The patient resumed school attendance, experienced reduced anxiety regarding seizures, and reported enhanced social engagement.

This case suggests that combined electroacupuncture and taVNS may be a promising non-pharmacological adjunct in the treatment of ASM-resistant JME, contributing to improved seizure control and multidimensional QOL outcomes.

## Linked entities

- **Chemicals:** sodium valproate (PubChem CID 16760703), clonazepam (PubChem CID 2802)
- **Diseases:** juvenile myoclonic epilepsy (MONDO:0009696)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** generalized tonic-clonic seizures (MESH:D012640), JME (MESH:D020190), myoclonic (MESH:D004831), Premonitory auras (MESH:D004827), bodily pain (MESH:D010146), anxiety (MESH:D001007)
- **Chemicals:** clonazepam (MESH:D002998), sodium valproate (MESH:D014635)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12644005/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12644005/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12644005/full.md

---
Source: https://tomesphere.com/paper/PMC12644005